Relmada Therapeutics Inc Major Shareholders & Ownership History
| Major Shareholder Name | Reporting Date | Shares Held | Market Value | Change in Shares | Ownership |
|---|---|---|---|---|---|
| JANUS HENDERSON GROUP PLC | 02/17/2026 | 7.27 M | $35.04 M | 100.00% | 21.90% |
| 02/17/2026 | 6.70 M | $32.36 M | 100.00% | 20.19% | |
| ADAGE CAPITAL PARTNERS GP, L.L.C. | 02/17/2026 | 4.27 M | $20.62 M | 100.00% | 12.86% |
| 02/13/2026 | 4.09 M | $19.74 M | 100.00% | 12.31% | |
| MARSHALL WACE, LLP | 02/13/2026 | 3.19 M | $15.41 M | 1,072.44% | 9.61% |
| IKARIAN CAPITAL, LLC | 02/18/2026 | 3.07 M | $14.82 M | 66.48% | 9.24% |
| ORBIMED ADVISORS LLC | 02/17/2026 | 2.61 M | $12.61 M | 100.00% | 7.87% |
| AMERIPRISE FINANCIAL INC | 02/17/2026 | 1.92 M | $9.27 M | 100.00% | 5.78% |
| DRIEHAUS CAPITAL MANAGEMENT LLC | 02/17/2026 | 1.88 M | $9.08 M | 154.05% | 5.66% |
| MILLENNIUM MANAGEMENT LLC | 02/17/2026 | 1.67 M | $8.08 M | 100.00% | 5.04% |
| BRAIDWELL LP | 02/17/2026 | 1.58 M | $7.64 M | 100.00% | 4.77% |
| BLACKROCK, INC. | 02/12/2026 | 1.27 M | $6.12 M | 149.51% | 3.82% |
| VANGUARD GROUP INC | 01/29/2026 | 1.20 M | $5.81 M | 187.47% | 3.63% |
| OPALEYE MANAGEMENT INC. | 04/13/2026 | 935.00 K | $4.52 M | 100.00% | 2.82% |
| GEODE CAPITAL MANAGEMENT, LLC | 02/09/2026 | 854.93 K | $4.13 M | 188.62% | 2.58% |
| BOOTHBAY FUND MANAGEMENT, LLC | 02/17/2026 | 835.30 K | $4.03 M | 20.49% | 2.52% |
| CI PRIVATE WEALTH, LLC | 03/09/2026 | 719.58 K | $3.44 M | 248.18% | 2.17% |
| TWO SIGMA INVESTMENTS, LP | 02/17/2026 | 572.84 K | $2.77 M | 229.95% | 1.73% |
| BALYASNY ASSET MANAGEMENT L.P. | 02/17/2026 | 547.85 K | $2.65 M | 100.00% | 1.65% |
| ACADIAN ASSET MANAGEMENT LLC | 02/10/2026 | 526.72 K | $2.54 M | -9.58% | 1.59% |
| DIADEMA PARTNERS LP | 02/17/2026 | 389.40 K | $1.88 M | 100.00% | 1.17% |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | 02/17/2026 | 385.94 K | $1.86 M | 178.81% | 1.16% |
| STATE STREET CORP | 02/13/2026 | 320.82 K | $1.55 M | 215.09% | 0.97% |
| ADVISORSHARES INVESTMENTS LLC | 02/10/2026 | 319.51 K | $1.54 M | -20.81% | 0.96% |
| JANE STREET GROUP, LLC | 02/12/2026 | 271.11 K | $1.31 M | 216.47% | 0.82% |
| PARSONS CAPITAL MANAGEMENT INC/RI | 01/13/2026 | 263.00 K | $1.27 M | 61.02% | 0.79% |
| PERSISTENT ASSET PARTNERS LTD | 02/17/2026 | 231.12 K | $1.12 M | 100.00% | 0.70% |
| DEUTSCHE BANK AG\ | 02/11/2026 | 224.85 K | $1.09 M | 0.00% | 0.68% |
| POINT72 ASSET MANAGEMENT, L.P. | 02/17/2026 | 187.38 K | $905.03 K | 100.00% | 0.56% |
| RENAISSANCE TECHNOLOGIES LLC | 02/12/2026 | 185.00 K | $893.55 K | 9.02% | 0.56% |
| NORTHERN TRUST CORP | 02/17/2026 | 165.45 K | $799.14 K | 180.32% | 0.50% |
| EAM INVESTORS, LLC | 02/12/2026 | 162.55 K | $785.13 K | 100.00% | 0.49% |
| TWO SIGMA ADVISERS, LP | 02/17/2026 | 162.20 K | $783.43 K | 318.04% | 0.49% |
| QUBE RESEARCH & TECHNOLOGIES LTD | 02/17/2026 | 155.53 K | $751.21 K | 100.00% | 0.47% |
| 04/02/2026 | 154.11 K | $744.35 K | 100.00% | 0.46% | |
| GOLDMAN SACHS GROUP INC | 03/25/2026 | 145.00 K | $700.35 K | 100.00% | 0.44% |
| RBF CAPITAL, LLC | 02/17/2026 | 140.00 K | $676.20 K | -14.25% | 0.42% |
| SQUAREPOINT OPS LLC | 02/13/2026 | 138.23 K | $667.67 K | 100.00% | 0.42% |
| MGO ONE SEVEN LLC | 02/03/2026 | 100.00 K | $483.00 K | 0.00% | 0.30% |
| SEI INVESTMENTS CO | 02/13/2026 | 98.97 K | $478.00 K | 100.00% | 0.30% |
| CAPTION MANAGEMENT, LLC | 02/17/2026 | 73.60 K | $355.49 K | 100.00% | 0.22% |
| EXODUSPOINT CAPITAL MANAGEMENT, LP | 02/17/2026 | 68.88 K | $332.71 K | 100.00% | 0.21% |
| OMERS ADMINISTRATION CORP | 02/13/2026 | 65.90 K | $318.30 K | 100.00% | 0.20% |
| MORGAN STANLEY | 02/13/2026 | 62.36 K | $301.19 K | 5,901.64% | 0.19% |
| BARCLAYS PLC | 02/13/2026 | 60.00 K | $289.80 K | 500.00% | 0.18% |
| LMR PARTNERS LLP | 02/17/2026 | 55.60 K | $268.55 K | 0.00% | 0.17% |
| QUADRATURE CAPITAL LTD | 02/17/2026 | 53.44 K | $258.14 K | 100.00% | 0.16% |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC | 02/13/2026 | 53.08 K | $256.38 K | 100.00% | 0.16% |
| APRICUS WEALTH, LLC | 01/15/2026 | 47.46 K | $229.24 K | 0.00% | 0.14% |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | 02/17/2026 | 47.20 K | $227.98 K | -28.48% | 0.14% |
Relmada Therapeutics Inc institutional Ownership - FAQ's
During the previous two years, 96 institutional investors and hedge funds held shares of Relmada Therapeutics Inc. The most heavily invested institutionals were:
PARSONS CAPITAL MANAGEMENT INC/RI: 352,500
AdvisorShares Investments LLC: 295,872
UBS Group AG: 126,672
Hillsdale Investment Management Inc.: 53,600
apricus wealth, LLC: 47,462
Robertson Stephens Wealth Management, LLC: 25,000
153.40% of Relmada Therapeutics Inc stock is owned by institutional investors.
Institutional investors have bought a total of 41.98 M shares in the last 24 months. This purchase volume represents approximately $301.00 M in transactions.